These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 37527496)

  • 1. Diabetes risk assessments and HbA1c-measurements in community pharmacies.
    Risøy AJ; Kjome RLS; Sandberg S; Sølvik UØ
    Int J Pharm Pract; 2023 Sep; 31(5):512-519. PubMed ID: 37527496
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Risk assessment and HbA1c measurement in Norwegian community pharmacies to identify people with undiagnosed type 2 diabetes - A feasibility study.
    Risøy AJ; Kjome RLS; Sandberg S; Sølvik UØ
    PLoS One; 2018; 13(2):e0191316. PubMed ID: 29474501
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Diabetes and cardiovascular disease risk screening model in community pharmacies in a developing primary healthcare system: a feasibility study.
    Alzubaidi HT; Chandir S; Hasan S; McNamara K; Cox R; Krass I
    BMJ Open; 2019 Nov; 9(11):e031246. PubMed ID: 31712336
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacists' experience of a diabetes risk-assessment service and analytical quality control in community pharmacies - A focus-group study.
    Risøy AJ; Skeide Kjome RL; Svensberg K; Råheim M; Sølvik UØ
    Res Social Adm Pharm; 2021 Jul; 17(7):1259-1266. PubMed ID: 34155978
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Implementation of point-of-care HbA1C instruments into community pharmacies: Initial development of a pathway for robust community testing.
    Radley A; Beer L; Rushdi D; Close H; McBurney S; Mackenzie A; Gourlay A; Barnett A; Grant A; Greig N; Dow E; Sutherland C
    Ann Clin Biochem; 2024 Jul; 61(4):273-283. PubMed ID: 37996254
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Participant and GP perspectives and experiences of screening for undiagnosed type 2 diabetes in community pharmacy during the Pharmacy Diabetes Screening Trial.
    Krass I; Twigg MJ; Mitchell B; Wilson F; Mohebbi M; Trinder P; Shih STF; Carter R; Versace VL; McNamara K
    BMC Health Serv Res; 2023 Dec; 23(1):1337. PubMed ID: 38041094
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Improving pharmaceutical practice in diabetes care using point-of-care glycated haemoglobin testing in the community pharmacy.
    Santana CR; de Oliveira MGG; Camargo MS; Moreira PMB; de Castro PR; Aguiar EC; Mistro S
    Int J Pharm Pract; 2024 Feb; 32(1):46-51. PubMed ID: 37936510
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Quality Control of Norwegian Pharmacy HbA1c Testing: A Modest Beginning.
    Ørvim Sølvik U; Risøy AJ; Kjome RLS; Sandberg S
    J Diabetes Sci Technol; 2018 Jul; 12(4):753-761. PubMed ID: 29619895
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Choice of HbA1c threshold for identifying individuals at high risk of type 2 diabetes and implications for diabetes prevention programmes: a cohort study.
    Rodgers LR; Hill AV; Dennis JM; Craig Z; May B; Hattersley AT; McDonald TJ; Andrews RC; Jones A; Shields BM
    BMC Med; 2021 Aug; 19(1):184. PubMed ID: 34412655
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Outcomes of a novel pharmacy screening intervention to address the burden of type 2 diabetes and cardiovascular disease in an Arabic-speaking country.
    Alzubaidi H; Hasan S; Saidawi W; Mc Namara K; Chandir S; Krass I
    Diabet Med; 2021 Aug; 38(8):e14598. PubMed ID: 33969536
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effectiveness of a collaborative diabetes screening campaign between community pharmacies and general practitioners.
    Murteira R; Cary M; Galante H; Romano S; Guerreiro JP; Rodrigues AT
    Prim Care Diabetes; 2023 Aug; 17(4):314-320. PubMed ID: 37156696
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmacy diabetes screening trial (PDST): Outcomes of a national clustered RCT comparing three screening methods for undiagnosed type 2 diabetes (T2DM) in community pharmacy.
    Krass I; Carter R; Mitchell B; Mohebbi M; Shih STF; Trinder P; Versace VL; Wilson F; Mc Namara KP
    Diabetes Res Clin Pract; 2023 Mar; 197():110566. PubMed ID: 36738834
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of diabetes duration on the relationship between glycaemic control and risk of death in older adults with type 2 diabetes.
    Ghouse J; Isaksen JL; Skov MW; Lind B; Svendsen JH; Kanters JK; Olesen MS; Holst AG; Nielsen JB
    Diabetes Obes Metab; 2020 Feb; 22(2):231-242. PubMed ID: 31596048
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
    Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
    [TBL] [Abstract][Full Text] [Related]  

  • 15. HbA1c presents low sensitivity as a post-pregnancy screening test for both diabetes and prediabetes in Greek women with history of gestational diabetes mellitus.
    Apostolakis M; Paschou SA; Zapanti E; Sarantopoulou V; Vasileiou V; Anastasiou E
    Hormones (Athens); 2018 Jun; 17(2):255-259. PubMed ID: 29949125
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The diagnostic accuracy of HbA
    Chivese T; Hirst J; Matizanadzo JT; Custodio M; Farmer A; Norris S; Levitt N
    Diabet Med; 2022 Apr; 39(4):e14754. PubMed ID: 34854127
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Diabetes care in Norwegian pharmacies: a descriptive study.
    Kjome RL; Sandberg S; Granås AG
    Pharm World Sci; 2008 Apr; 30(2):191-8. PubMed ID: 17891470
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Community pharmacy type 2 diabetes risk assessment: demographics and risk results.
    Twigg MJ; Wright DJ; Thornley T; Haynes L
    Int J Pharm Pract; 2015 Feb; 23(1):80-2. PubMed ID: 25047239
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Exploration and Validation of the Performance of Hemoglobin A1c in Detecting Diabetes in Community-Dwellers With Hypertension.
    Qiu S; Du Z; Li W; Chen J; Wu H; Liu J; Cai M; Wang B; Guo H; Sun Z
    Ann Lab Med; 2020 Nov; 40(6):457-465. PubMed ID: 32539301
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A pragmatic and scalable strategy using mobile technology to promote sustained lifestyle changes to prevent type 2 diabetes in India-Outcome of screening.
    Priscilla S; Nanditha A; Simon M; Satheesh K; Kumar S; Shetty AS; Snehalatha C; Johnston DG; Godsland IF; Wareham NJ; Ramachandran A
    Diabetes Res Clin Pract; 2015 Dec; 110(3):335-40. PubMed ID: 26547503
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.